Collectively, these findings suggest that STING plays a detrimental role in the pathogenesis of MASLD/MASH, with cGAS-STING pathway activation primarily occurring in non-parenchymal cells, particularly hepatic macrophages, contributing to their pro-inflammatory effects. Here, CGAS is linked to metabolic dysfunction-associated steatotic liver disease.